From Heartache to Healthtech Breakthrough: Bilihome Secures $1.95M to Transform Newborn Care

We are excited to announce that Bilihome has successfully raised €1,950,000 in its recent funding round, marking a significant milestone in its mission to transform neonatal care. Born from the personal journey of a thoughtful dad who experienced the heartache of family separation after a stressful birth, Bilihome was established in 2019 with a clear vision: to bring essential medical care out of the hospital and closer to home. After witnessing his own family’s struggle when his baby boy developed jaundice and required phototherapy in the NICU, founder Rick was inspired to create a wearable phototherapy device that would allow infants to receive critical treatment in the comfort of their own homes. This breakthrough innovation not only promises to alleviate the emotional and logistical challenges families face during such trying moments but also aims to redefine the standards of newborn healthcare. As a company featured by NLC – The European Healthtech Venture Builder in Amsterdam, Bilihome is well-positioned to make a lasting impact in the healthcare industry. The newly raised funds will be dedicated to enhancing the device’s technology, scaling production capabilities, and broadening market outreach, ensuring that more families can benefit from this compassionate and proactive approach to neonatal care. With every step, Bilihome remains committed to its core goal: changing perceptions and practices around the medical care of newborns and their families, by empowering parents and improving outcomes for the youngest patients. This substantial investment is a testament to the confidence investors have in Bilihome’s innovative approach and unwavering dedication to bettering the lives of families across Europe and beyond.